Venn Life Sciences Holdings Plc

Venn Life Sciences (VENN)

Buy
Sell
Company name:Venn Life Sciences Holdings Plc
EPIC:VENNTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00B9275X97
Market Segment:ASQ1Share Type:DE
WWW Address:http://ir.vennlifesciences.com/content/investor/aim_rules.aspDescription:ORD 0.1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 6.85 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 6.70 7.00 - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 4.89 71.40 -0.00 -6.29 - - - -

Venn Life Sciences Key Figures

(at previous day's close)
Market Cap.4.89m
Shares In Issue71.40m
Prev. Close6.85
PE Ratio- 
Dividend Yield-%
EPS - basic-6.29p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-1.39p
Return On Equity (ROE)-107.59%
Operating Margin-35.99%
PEG Factor- 
EPS Growth Rate-186.67%
Dividends PS Growth Rate-%
Net Debt2.88m
Gross Gearing49.65%
Quick Assets6.39m
Net Working Capital3.51m
Intangibles / Fixed Assets64.30%
Turnover PS17.53p
Pre-Tax Profit PS-6.31p
Retained Profit PS-5.91p
Cash PS1.38p
Net Cash PS-2.65p
Net Tangible Asset Value PS *4.24p
Net Asset Value PS5.49p
Spread0.30 (4.29%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Venn Life Sciences Balance Sheet

L^VENN:Liabilities+EQL^VENN:Assets

Share Price Performance

Sorry No Data Available

Share Price Chart (5 years)

Venn Life Sciences Historic Returns

Sorry No Data Available

Venn Life Sciences Key Management Ratios

Venn Life Sciences Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.47 
Tobin's Q Ratio (excl. intangibles)0.62 
Dividend Yield-%
Market-to-Book Ratio1.25 
Price-to-Pre-Tax Profit PS-1.09 
Price-to-Retained Profit PS-1.16 
Price-to-Cash Flow PS-4.92 
Price-to-Sales PS0.39 
Price-to-Net Tangible Asset Value PS1.62 
Price-to-Cash PS4.95 
Net Working Capital PS4.92 
Price Pct to Working Capital PS1.39%
Earnings Yield-%
Average PE281.68 
Years in average2 
PE to PE average-%

Venn Life Sciences Financial Ratios

(Leverage Ratios)
Debt Ratio20.05%
Debt-to-Equity Ratio0.25 
Debt-to-Equity Ratio (excl. Intgbl)0.33 
Debt-to-Equity Market Value0.20 
Net Gearing36.97%
Net Gearing (excl. Intangibles)41.78%
Gross Gearing49.65%
Gross Gearing (excl. Intangibles)56.11%
Gearing Under 1 Year37.03%
Gearing Under 1 Year (excl. Intgbl)41.84%
Assets/Equity1.99 
Cash/Equity25.19 
(Liquidity Ratios)
Net Working Capital to Total Assets45.08%
Current Ratio2.22 
Quick Ratio (Acid Test)2.22 
Liquidity Ratio0.34 
Cash & Equiv/Current Assets15.45%
(Solvency Ratios)
Enterprise Value4.89m
CFO/Sales-0.08 
CFO/Attributable Profit- 
CFO/Assets-0.13 
CFO/Debt-0.26 
Total Debt/Equity Market Value0.79 
Total Debt/Sales0.31 
Total Debt/Pre-Tax Profit-0.86 
Total Debt3.87m
Total Debt/Net Current Assets1.10%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs2 
Beta (60-Mnth)Beta (36-Mnth)
-0.0046-0.0008

Venn Life Sciences Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-91.89%
Return On Assets (ROA)-40.41%
Net Profit Margin-33.69%
Assets Turnover1.20 
Return On Equity (ROE)-107.59%
Return On Investment (ROI)-59.37%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-33.69%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.91 
Fixed Assets Turnover3.79 
Current Assets Turnover1.75 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales0.83 
Debtors-to-Sales47.90%
Debt Collection Period174.85Days

Venn Life Sciences Dividends

Sorry No Data Available

Venn Life Sciences Fundamentals
 31 Dec 2015 (EUR)31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)
turnover11.47100.00%17.91100.00%17.41100.00%13.92100.00%m
pre tax profit-0.33-2.85%-0.91-5.10%-1.67-9.57%-5.01-35.99%m
attributable profit0.020.13%0.532.97%-1.54-8.84%-4.69-33.69%m
retained profit0.020.13%0.532.97%-1.54-8.84%-4.69-33.69%m
eps - basic0.04 0.88 -2.55 -7.31 
eps - diluted0.04 0.79 -2.35 -7.31 
dividends per share- - - - 

Venn Life Sciences Balance Sheet

 31 Dec 2015 (EUR)31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)
L^VENN:Liabilities+EQL^VENN:AssetsL^VENN:Liabilities+EQL^VENN:AssetsL^VENN:Liabilities+EQL^VENN:AssetsL^VENN:Liabilities+EQL^VENN:Assets
 31 Dec 2015 (EUR)31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)
ASSETS
fixed assets fixed assets0.382.50%0.191.30%0.312.55%0.263.04%m
intangibles intangibles5.4435.70%4.0627.59%4.0333.03%1.0011.50%m
fixed investments fixed investments0.030.20%2.0413.85%0.715.82%0.293.35%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors5.5836.66%5.0234.13%5.9848.97%6.0169.43%m
cash & securities cash & securities3.8024.94%3.4023.13%1.189.62%1.1012.68%m
TOTAL15.23100%14.71100%12.21100%8.66100%m
LIABILITIES
creditors - short creditors - short4.9532.47%4.2628.93%3.4628.31%3.2137.03%m
creditors - long creditors - long0.050.34%0.030.17%--%1.0912.62%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL5.0032.81%4.2829.10%3.4628.31%4.3049.65%m
EQUITY
ord cap, reserves ord cap, reserves9.9165.04%10.4370.90%8.7671.69%4.3650.35%m
prefs, minorities prefs, minorities0.332.15%--%--%--%m
TOTAL10.2367.19%10.4370.90%8.7671.69%4.3650.35%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Venn Life Sciences Cash Flow Statement

31 Dec 2015 (EUR)31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)
Operating CF-2.15-0.34-1.32-1.11m
Pre-Financing CF-4.97-0.34-2.33-1.21m
Retained CF3.20-0.40-2.37-0.08m

Venn Life Sciences Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
VENN
Venn Life ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210306 04:57:46